Sharon Townson
Hoofd Techniek/Wetenschap/O&O bij MONTE ROSA THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Sharon Townson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | - |
| Corporate Officer/Principal | 01-07-2020 | 01-12-2020 |
Loopbaan van Sharon Townson
Eerdere bekende functies van Sharon Townson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-04-2019 | 01-06-2020 |
| Corporate Officer/Principal | 01-04-2019 | 01-06-2020 | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-06-2013 | 01-12-2018 |
Opleiding van Sharon Townson
| University of Manchester Institute of Science & Technology | Doctorate Degree |
| University of Salford | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
- Beurs
- Insiders
- Sharon Townson
- Ervaring
